MD Anderson Morgan Welch Inflammatory Breast Cancer Program,
Congratulations to Dr. Michal Mego, James Reuben, and the team to successfully publish the role of circulating tumor cells in…
Congratulations to Dr. Michal Mego, James Reuben, and the team to successfully publish the role of circulating tumor cells in…
Circulating tumor cells (CTCs) are an independent prognostic factor for progression-free survival (PFS) and overall survival (OS…
Circulating tumor cells can be strong predictor of prognosis for inflammatory #breastcancer. http://ow.ly/Hb2de
Circulating tumor cells can be strong predictor of prognosis for inflammatory #breastcancer. http://ow.ly/Hb2de